South America Sleep Apnea Diagnostics Market

Market Introduction

South America region for the estimating the market for the sleep apnea diagnostics consist of countries such as Brazil, Argentina, and rest of South America. Brazil settings is expected to be the fastest growing segment during the forecast period. Chronic sleep restriction is often related to the changes due to modern life, such as work-related demands, social and domestic responsibilities, and current lifestyles. Furthermore, sleep disturbances are becoming increasingly prevalent, having a clinically significant influence on public health. Chronic sleep disorders affect ten percent of the American population, posing serious health and safety risks. Similarly, the population of So Paulo, Brazil's largest city, has seen an increase in sleep issues such as snoring, insomnia, and bruxism during the last three decades. The Brazilian Sleep Association, the Brazilian Neurology Academy, the Brazilian Otorhinolaryngology and Facial Cervical Surgery Association, the Brazilian Pediatric Society, the Brazilian Pulmonology and Phthisiology Society, and the Brazilian Clinical Neurophysiology Society collaborated on a project to standardise the diagnosis and treatment of OSAS in Brazilian adults, children, and adolescents. A study in Brazilian patients verifies the efficacy of the adjustable PM Positioner for the treatment of OSA.

The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the second wave of corona infection. Amongst which Brazil has registered most of the deaths. It is anticipated that the region will likely force a second lockdown, which will ultimately hamper the healthcare industry in the area. However, the outbreak of COVID–19 has critically affected the flow of medical services in the region. Post-coronavirus disease lockdown had a significant impact on sleep, as demonstrated by an increase in insomnia reports, particularly among women, but had no effect on adherence to positive airway pressure or self-reported sleep length. According to a poll, the vast majority claimed that in-laboratory sleep investigations were nearly discontinued, while a lesser percentage reported declines in home sleep apnea tests. There has been a significant increase in the usage of telemedicine, with the majority of respondents expecting this trend to continue in the future.

South America Sleep Apnea Diagnostics Strategic Insights

Strategic insights for the South America Sleep Apnea Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South America Sleep Apnea Diagnostics Report Scope

South America Sleep Apnea Diagnostics Regional Insights

The geographic scope of the South America Sleep Apnea Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The sleep apnea diagnostics market in South America is expected to grow US$ 38.30 million in 2021 to US$ 51.69 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. Advancements in knowledge in biology and engineering have equally enhanced the various medical devices such as polysomnography (PSG) device, home sleep testing devices, and others. Many industry players have come up with innovative types of sleep apnea diagnostic devices in the last few years. For instance, in July 2019, CleveMed, a leading home sleep apnea testing company, announces the launch of a new comprehensive sleep care service designed for patients with sleep disorders in the private pay market. Furthermore, in September 2019, Koninklijke Philips N.V. launched Philips NightBalance, a prescription sleep position therapy device designed for patients with positional OSA. The product is likely a non-inferior treatment to continuous positive airway pressure (CPAP) and demonstrate high adherence rates among positional OSA patients. With such advancements, the market is registering tremendous growth.

Key Market Segments

In terms of product, the polysomnography (PSG) device segment accounted for the largest share of the South America sleep apnea diagnostics market in 2021. In term of end user, hospitals and sleep laboratories segment held a larger market share of the South America sleep apnea diagnostics market in 2021.         

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the sleep apnea diagnostics market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are ResMed, Inc.; Nihon Kohden Corporation LLC; SOMNOmedics GmbH; Cleveland Medical Devices Inc.; Koninklijke Philips N.V.; Natus Medical Incorporated; Itamar Medical Ltd.; and Compumedics Limited among others.

Reasons to buy report

• To understand the South America sleep apnea diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for South America sleep apnea diagnostics market
• Efficiently plan M&A and partnership deals in South America sleep apnea diagnostics market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South America sleep apnea diagnostics market
• Obtain market revenue forecast for market by various segments from 2021-2028 in South America region.

South America Sleep Apnea Diagnostics Market Segmentation

South America Sleep Apnea Diagnostics Market – By Product

• Polysomnography (PSG) Device
• Home Sleep Testing Devices
• Oximeter

• FingerTip Oximeter
• Handheld Oximeter
• Wrist-worn Oximeter
• Tabletop Oximeter

• Actigraphy Monitoring Device
• Sleep Apnea Screening Device

South America Sleep Apnea Diagnostics Market – By

End User

• Hospitals and Sleep Laboratories
• Home Care Settings

South America Sleep Apnea Diagnostics Market – By

Country

• Brazil
• Argentina
• Rest of South America

South America Sleep Apnea Diagnostics Market – Companies Mentioned

• ResMed Inc.
• Nihon Kohden Corporation LLC
• SOMNOmedics GmbH
• Cleveland Medical Devices Inc. 
• Koninklijke Philips N.V.
• Natus Medical Incorporated
• Itamar Medical Ltd.
• Compumedics Limited